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Arboviruses that are transmitted to humans bymosquitoes represent one of the
most important causes of febrile illness worldwide. In recent decades, we have
witnessed a dramatic re-emergence of several mosquito-borne arboviruses,
including dengue virus (DENV), West Nile virus (WNV), chikungunya virus
(CHIKV) and Zika virus (ZIKV). DENV is currently the most common mos-
quito-borne arbovirus, with an estimated 390 million infections worldwide
annually. Despite a global effort, no specific therapeutic strategies are available
to combat the diseases caused by these viruses. Multiple cellular pathways
modulate the outcome of infection by either promoting or hampering viral
replication and/or pathogenesis, and autophagy appears to be one of them.
Autophagy is a degradative pathway generally induced to counteract viral
infection. Viruses, however, have evolved strategies to subvert this pathway
and to hijack autophagy components for their own benefit. In this review,
we will focus on the role of autophagy in mosquito-borne arboviruses with
emphasis on DENV, CHIKV, WNV and ZIKV, due to their epidemiological
importance and high disease burden.1. Introduction
1.1. The epidemiology of arboviruses
Arbovirus (arthropod-borne virus) is an ecological term that groups viruses trans-
mitted to their hosts through the bite of blood-feeding arthropods, such as ticks,
mosquitoes and sandflies [1]. It comprises over 500 viruses, which are classified
into six main taxonomic groups: family Togaviridae (genus Alphavirus), family
Flaviviridae (genus Flavivirus), order Bunyavirales (families Orthobunyavirus,
Nairovirus and Phlebovirus), family Rhabdoviridae (7 genera), family Orthomyxoviri-
dae (genus Thogotovirus) and family Reoviridae [2,3]. Some of these viruses have
become major human pathogens, due to their rapid dispersal around the world
or their persistence throughout the years. This is primarily linked to the expansion
of the habitats of their vectors as a consequence of global warming, unplanned
urbanization andunintentional transport [4]. In recent decades,we havewitnessed
a dramatic re-emergence of arboviruses transmitted to humans by mosquitoes of
the Culex spp. and/or Aedes spp., such as dengue virus (DENV), West Nile virus
(WNV), chikungunya virus (CHIKV) and Zika virus (ZIKV), which are currently
spread in both the western and eastern hemispheres [5]. It has been estimated
that the population at risk of DENV and CHIKV infection is approximately 2.5
and 1.3 billion people, respectively [6–8].
Most individuals infected with mosquito-borne arboviruses remain asymp-
tomatic. During symptomatic infections, however, individuals often develop an
undifferentiated febrile illness, accompanied by (severe) headache, body aches,
joint pains, vomiting, diarrhoea and rash [9]. In the case of DENV, for example,




250–100 million individuals develop a symptomatic infection
[10]. CHIKV infection, on the other hand, is associated with a
relatively high symptomatic attack rate, as 50–97% of the
infected individuals develop a clinically apparent disease [11].
Additionally, more severe clinical manifestations have been
reported in a small subset of infected people, such asmeningitis
or encephalitis (e.g. WNV), debilitating chronic arthralgia
(e.g. CHIKV), vascular leak and haemorrhage (e.g. DENV), or
congenital malformations and microcephaly (e.g. ZIKV)
[12,13]. In most situations, symptoms resolve without compli-
cations, yet prolonged fatigue, depression, chronic pain and
permanent effects in the central nervous system (CNS) have
been reported for some of these viruses [14,15]. In rare cases,
arbovirus infections lead to death [14,15].
Despite the global threat of DENV, WNV, ZIKV and
CHIKV, vaccines and treatment possibilities for the infections
caused by these viruses are scarce. Treatments remain pallia-
tive as no specific antivirals are available thus far [16–18].
A substantial number of studies have, however, explored
several treatment strategies, but currently, none of them is
approved for human use [19]. Effective prophylactic immuniz-
ation exists for few arboviruses such as Japanese encephalitis
virus and yellow fever virus [20]. In addition, multiple
efforts have been made regarding the development of DENV,
ZIKV, WNV and CHIKV vaccines. Dengvaxia (also known
as CYD-TDV) developed by Sanofi Pasteur has recently
become the first approved DENV vaccine [21,22]. Although it
has been licensed in several countries in South and Central
America, and in the Philippines, the introduction of this vac-
cine to mass immunization programmes is currently not
recommended by the World Health Organization due to
safety issues [23]. In the case of CHIKV, several vaccine candi-
dates have been developed, including a recombinant measles
virus expressing CHIKV antigens and a virus-like particle vac-
cine, which have successfully completed phase I clinical trials
[24,25]. Given the high disease burden in particular of DENV
and CHIKV, it is of utmost importance to further develop
promising existing strategies and to explore new therapeutic
and immunization methodologies to combat these viruses.
Understanding the arbovirus virus–host interaction is crucial
for this goal.
1.2. Replication cycle of flavi- and alphaviruses
DENV, WNV and ZIKV are enveloped single-stranded
positive-sense RNA (ssRNAþ) viruses that belong to the Flavi-
virus genus. The genomic RNA is packaged by capsid (C)
proteins to form the nucleocapsid [26]. The flaviviral genome
is 10–12 kb long and it encodes for a single open reading
frame (ORF) [27]. The flavivirus ssRNAþ has a 50-cap structure
but lacks a 30-poly(A) tail [27]. It also contains 50- and
30-untranslated regions (UTR) that fold into secondary struc-
tures and are conserved among divergent flaviviruses
[27–31]. The nucleocapsid is surrounded by a host cell-derived
envelope inwhich two transmembrane proteins, themembrane
(M) protein and the envelope (E) protein, are inserted [32,33].
During infection, the E protein mediates the attachment of
virus particles to the cell surface (figure 1). Multiple receptors
have been identified and their usage depends on the cell type
and virus [34]. Virus recognition is followed by internalization
of the virion through endocytosis and subsequent fusion
between the membrane of the viral particle and the limiting
membrane of late, Ras-related protein 7A (RAB7A)-positiveacidic endosomes, facilitated by the E protein [35–38]
(figure 1). Once the RNA is delivered to the cytoplasm, the
ssRNAþ is translated by ribosomes associated with the
rough endoplasmic reticulum (ER) [39].
RNA translation generates a polyprotein of approximately
370 kDa in length that is inserted into the ER membrane and
cleaved co- and post-translationally by viral and cellular pro-
teases, into the individual proteins: the E, C and precursor
M (prM) structural proteins, and the NS1, NS2A/B, NS3,
NS4A/B, NS5 non-structural (NS) proteins. Extensive ER-
derived membrane rearrangements are induced by the viral
proteins NS4 and NS3, which serve as scaffolds for the assem-
bly of viral replication complexes [40,41] (figure 1). The NS
proteins are required for RNA replication and pathogenesis
[27,42]. For instance, DENV NS2A, NS2B3, NS4A, NS4B and
NS5, and WNV NS1 and NS4B are involved in immune
evasion [43]. The viral NS5 polymerase synthesizes new
ssRNAþ through the generation of an ssRNA2 intermediary
strand, and this can be used for new rounds of translation or
as a substrate for encapsidation in progeny virions (figure 1).
During encapsulation, viral RNA is packaged into the nucleo-
capsid by interaction and assembly of multiple copies of the
C protein [44]. The envelope prMandE proteins form heterodi-
mers that are oriented into the lumen of the ER and associate
into trimers to create a curved surface lattice, which guides
the budding of the nucleocapsid into the ER to form immature
viral particles [45] (figure 1). These immature particles are
transported through the secretory pathway to the trans-Golgi
network (TGN), where the prM/E envelope proteins undergo
conformational changes thereby allowing the host protease
furin to process prM into M, which drives maturation of the
virus [33,46]. Progeny flavivirus particles are finally secreted
from the cells by exocytosis [13] (figure 1).
CHIKV, a member of the Alphavirus genus, has a ssRNAþ
genome of 11.8 kb. The RNA is packaged by the capsid
protein (C) to form a nucleocapsid. The nucleocapsid is sur-
rounded by an envelope wherein the two transmembrane
glycoproteins, E1 and E2, are anchored [47]. The CHIKV
genome resembles eukaryotic mRNAs as it has a 50-cap
structure and a 30-poly-adenine tail [48]. It also has 50- and
30-non-translatable regions (NTR) composed of 76 nucleotides
and 526 nucleotides, respectively [48]. Unlike flaviviruses,
the CHIKV genome contains two ORFs, separated by a
68-nucleotide long untranslated junction region [48].
The E2 protein mediates binding of the virus to cell sur-
face receptors, which is followed by internalization of the
virus via clathrin-mediated endocytosis and subsequent
E1-mediated fusion between the virion membrane and the
limiting membrane of acidic early, RAB5A-positive endo-
somes [49] (figure 2). The subsequent disassembly of the
capsid is thought to occur upon binding of the C protein to
the large ribosomal subunit, which leads to the release of
the viral RNA [50] (figure 2).
Upon release of the ssRNAþ into the cytoplasm, the
50-ORF is rapidly translated into a polyprotein (P1234), the
viral replicase, which is composed by the nsP1, nsP2, nsP3
and nsP4 NS proteins of the virus [51] (figure 2). First,
P1234 is cleaved in cis by nsP2 to generate P123 and nsP4
[52], which leads to the formation of an unstable replication
complex that synthesizes ssRNA2 intermediates in struc-
tures near the plasma membrane known as spherules [53].
Later in infection, these spherules are relocated to the limiting
membrane of small cytoplasmic vesicles, giving rise to























Figure 1. Flavivirus replication cycle. Flavivirus infection starts with the binding of the virion to cell receptors (step 1), which subsequently triggers the intern-
alization of the viral particle via clathrin-mediated endocytosis (step 2). The acidic environment of late endosomes triggers the fusion of the virion with the limiting
membrane of this organelle, resulting in the release of the genomic RNA into the cell cytoplasm (step 3). Translation of the viral RNA generates a polyprotein that is
proteolytically cleaved into the non-structural (NS) and the structural proteins (step 4). NS proteins facilitate RNA replication leading to the formation of ssRNA2
(green) and ssRNAþ (blue) transcripts (step 5). Progeny ssRNAþ is packaged by the capsid protein (C) to form the nucleocapsid. Viral assembly takes place in the
ER (step 6), resulting in immature virions that are transported to the TGN through the secretory pathway, where furin-mediated cleavage of prM into M generates





3cytopathic viral replication vacuoles [54]. Once P123-nsP4
levels reach a stoichiometric threshold, the polyprotein is
further cleaved to generate the individual NS proteins. There-
after, the synthesis of ssRNAþ and subgenomic RNA
(sgRNA) from the 30-ORF [55,56] is initiated. Herein, the
untranslated junction between the two ORFs participates as
an internal transcription promotor of the sgRNA [48].
Translation of approximately 5 kb sgRNA generates a
second polyprotein that produces the structural proteins [48]
(figure 2). Once the C protein is translated, it auto-cleaves
and a signal sequence in E3 directs the translocation of the
remaining structural polyprotein (E3, E2, 6 K or TF and E1)
into the ER membrane [57]. The C protein subsequently recog-
nizes specific motifs in the 50-end of the newly synthesized
ssRNAþ to form nucleocapsid-like structures [58]. Meanwhile,
host proteases catalyse the cleavage of the individual structural
proteins to generate pE2 (fused E3–E2), 6 K or TF and E1 [59].
pE2 and E1 heterodimers undergo post-translational
modifications and are transported through the TGN, wherefurin-mediated cleavage of pE2 into E2 and a soluble E3 pep-
tide leads to the formation of E2–E1 heterodimers that are
directed to the plasma membrane [60] (figure 2). Subsequent
interaction of E2 proteins with a newly formed nucleocapsid
drives virus assembly and budding from the plasma mem-
brane [48] (figure 2). Although the function of 6 K protein
in the replication cycle of alphaviruses is not fully under-
stood, it is thought, among other functions, to interact with
E1 and pE2 to regulate their trafficking to the plasma mem-
brane [61]. The TF protein is generated from a ribosomal
frameshift that occurs during translation of the 6 K gene
and is believed to mediate CHIKV assembly and release,
although its full function remains to be determined [62].
1.3. Autophagy
Autophagy is a catabolic pathway that is highly conser-
ved among eukaryotes, in which cytoplasmic components,
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Figure 2. CHIKV replication cycle. CHIKV infection is initiated by the binding of the viral particle to cell receptors (step 1), which triggers the internalization of the
virion via clathrin-mediated endocytosis (step 2). Subsequent fusion of the viral particle with the early endosome limiting membrane leads to the cytoplasmic
release of the genomic RNA release (step 3). Genomic RNA is initially translated from the 50-ORF into the viral replicase (P1234) (step 4), which replicate the
ssRNA2 (green) and the ssRNA2 (blue) (step 5). The viral replicase also replicates the subgenomic RNA from the 30-ORF (step 6), which serves as the template
for the translation of structural proteins (step 7). The structural pE2 and E1 proteins are inserted into the ER and they are first processed in this organelle and then in
the TGN, where furin-mediated proteolytical cleavage generates mature E2–E1 heterodimers that are exported to the plasma membrane (step 8). Genomic RNA is
packaged by the C protein (step 9) and by interacting with the E2–E1 heterodimers, initiate the budding of the viral particle from the plasma membrane (step 10)




4complexes/aggregates are delivered into lysosomes for degra-
dation and recycling of their basic components [63]. Three
main types of autophagy are recognized in mammals: (1)
macroautophagy, which involves the formation of double-
membrane vesicles known as autophagosomes; (2) microauto-
phagy, where the cytosolic material is directly engulfed
through invagination of the lysosome limiting membrane;
and (3) chaperone-mediated autophagy, in which proteins
with a specific targeting motif are recognized by the cytosolic
chaperone heat-shock cognate protein of 70 kDa (HSC70) and
translocated into lysosomes through a channel formed on the
surface of these organelles by LAMP2A [64,65]. Although
these three pathways collectively support the overall intracellu-
lar autophagic activity, macroautophagy is the process that has
been best characterized so far.
Macroautophagy, hereafter referred to as autophagy, con-
tributes to the maintenance of cellular homeostasis by
providing a mechanism for protein and organelle quality con-
trol. As a result, it plays a crucial role in numerousphysiological processes and pathological situations, such
as cell development and cell differentiation, post-natal survi-
val, immune response, neurodegenerative diseases, cancer,
ageing and inflammation [66–68]. Autophagy is usually con-
sidered as a rather non-selective bulk degradation pathway,
yet, it has become clear that it also contributes to intracellular
homeostasis by selectively turning over specific substrates
[69]. Distinctive terms have been coined to describe these
types of selective autophagy, including mitophagy (mitochon-
dria), lipophagy (lipid droplets), aggrephagy (aggregated
proteins), pexophagy (peroxisomes), ribophagy (ribosomes),
reticulophagy (ER) and xenophagy (pathogens) [70]. Auto-
phagy is induced in response to a variety of cellular stressors,
including nutrient deprivation and viral infections [71].
During starvation, the nutrient and energy-sensing kinases
mechanistic target of rapamycin (mTOR) complex 1
(mTORC1) and the AMP-activated protein kinase (AMPK)
directly regulate autophagy initiation (see below) [72]. Viral
infection induces ER and oxidative stress, which in turn can
Table 1. Key proteins involved in autophagosome formation and its fusion with lysosomes in mammalian cells.
step of autophagy functional cluster components
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5also trigger autophagy [73,74]. Upon ER stress, cells activate a
series of adaptive mechanisms known as the unfolded protein
response (UPR), to cope with the accumulation of misfolded
proteins [75]. The UPR promotes the transcription of multiple
groups of genes, including several of those involved in autop-
hagy [76]. On the other hand, reactive oxygen species (ROS)
production can directly activate autophagy (through
mTORC1), to eliminate the source of oxidative stress and pro-
tect cells from oxidative damage [73]. Besides induction
through cellular stress, autophagy can also be activated by
the expression of several viral proteins [74,77].
The canonical form of autophagy is governed by five
major functional clusters of proteins (table 1), which are com-
posed by the so-called autophagy-related (ATG) proteins and
work in concert in four sequential steps: (1) initiation and de
novo formation of the phagophore (or isolation membrane),
(2) elongation and closure of the phagophore to generate an
autophagosome; (3) autophagosome–lysosome fusion and
(4) cargo degradation and cytosolic recycling of the resulting
metabolites (figure 3) [68,78]. Most of the ATG proteins that
participate in these steps are localized in the cytoplasm andonly associate with the forming autophagosomes upon
autophagy induction [79]. This characteristic can be exploited
for quantification of autophagosome biogenesis, but given
the multistep nature of this pathway, it is also important to
consider the autophagic degradative activity [80]. The rate
at which cargos are recognized, segregated and degraded
through the autophagy pathway is defined as autophagic
flux and it can be measured using diverse methods reviewed
elsewhere [80].
The formation of the phagophore is initiated by heteroty-
pic fusion of vesicles, which are probably derived from the
ER and recycling endosomes, although other possible mem-
brane sources like the plasma membrane and mitochondria
could also be involved [81–83]. The ULK kinase complex is
the first functional cluster of proteins assembling at the site
of phagophore nucleation, and it is formed by the Unc-51
like autophagy activating kinase 1 or 2 (ULK1/2) and the
regulatory subunits ATG13, ATG101 and focal adhesion
kinase family interacting protein of 200 kD (FIP200) [84].
This complex regulates phagophore biogenesis and is modu-












Figure 3. Schematic representation of the key steps of the autophagy process. Autophagy initiation is under the control of several regulatory signals such as ER
stress, ROS production, AMPK or mTORC1 signalling, and the presence of microorganisms. Autophagy begins with the formation of a small cistern, the phagophore,
which elongates and sequesters cytoplasmic components such as protein aggregates and organelles. Closure of the phagophore generates a double-membrane
vesicle-denominated autophagosome. Subsequent fusion of the autophagosome with lysosomes results in the formation of autolysosomes, where lysosomal




6upstream signals including growth factors and nutrients such
as amino acids and glucose [85] (figure 3). mTORC1 represses
autophagy through direct phosphorylation of ULK1 and
ATG13; and the absence of the aforementioned signals triggers
autophagy initiation [72]. ULK1 is also positively regulated by
AMPK, which senses the cellular energy status and is activated
when intracellular AMP increases, reflecting a decrease in the
availability of ATP [86]. Once autophagy is initiated, the auto-
phagy-specific class III phosphatidylinositol 3-kinase (PI3 K-III)
complex, which is composed by the phosphatidylinositol
3-kinase VPS34, Beclin-1 (BECN1), p150 and ATG14 L along
withAMBRA1, associates at the sites of phagophore nucleation
[87]. This complex is responsible for the local synthesis of phos-
phatidylinositol-3-phosphate (PI3P), a lipid that is important
for the subsequent steps of autophagosome biogenesis [87].
The last functional cluster of proteins that seems to be essential
in the early phases of phagophore nucleation is comprised by
the transmembrane protein ATG9A and its trafficking machin-
ery, which includes some of the PtdIns3P binding proteins,
WD-repeat protein interacting with phosphoinositides 1–4
(WIPI1–4) and ATG2A/2B [88].
Once the phagophore is formed, the PI3P generated by the
PI3 K-III complex promotes the association of additional PI3P-
binding proteins, which facilitate the recruitment of additional
factors that oligomerize into functional complexes that partici-
pate in the elongation step (table 1) [89]. Recruited proteins
include components of the two ubiquitin-like conjugation sys-
tems, which promote both phagophore elongation and closure
[90]. The first ubiquitin-like conjugation system leads to the for-
mation of an oligomer constituted by the ATG12–ATG5
conjugate, and ATG16L1, which is tightly associated with the
expanding phagophore [63]. The formation of this complex is
mediated by the E1 enzyme ATG7 and the E2 enzyme
ATG10, which covalently link the ubiquitin-like ATG12 to
ATG5, and the resulting ATG12–ATG5 conjugate interacts
with ATG16L1 [68]. The second ubiquitin-like conjugation
system leads to the N-terminal lipidation of the members of
microtubule-associated protein 1A light chain 3 (LC3) protein
family, which is composed in humans by LC3A, LC3B, LC3C
and theGamma-aminobutyric acid receptor-associated protein
(GABARAP), GABARAPL1 and GABARAPL2 [91]. Members
of the ATG4 cysteine protease family (i.e. ATG4A to ATG4D)
cleave LC3 proteins at the C-terminal to expose a glycine resi-
due, producing LC3-I [92]. Upon autophagy induction,
cytoplasmic LC3-I is activated by ATG7 and, via the E2
enzyme ATG3, is conjugated to the amino group ofphosphatidylethanolamine (PE) molecules present in the
phagophore membrane, to produce LC3-II [93]. This later step
is guided by the ATG12–ATG5–ATG16L1 oligomer, which
enhances both the E2 enzyme activity of ATG3 and recruits it
to the forming autophagosome [94]. Once the expansion of
the autophagosome is completed, most of the components of
the ATGmachinery dissociate from the surface of these vesicles
and relocate to the cytoplasm, where they can be re-used.
During selective autophagy, autophagy receptors, such as
Sequestosome-1 (p62/SQSTM1), next to BRCA1 gene 1 protein
(NBR1), calcium-binding and coiled-coil domain-containing
protein 2 (NDP52), Optineurin (OPTN), FUN14 domain-
containing protein 1 (FUNDC1) and BCL2/adenovirus E1B
19 kDa protein-interacting protein 3 (BNIP3); direct specific
cargos to autophagosomes via their LC3-interacting-region
domains, which mediate the interaction with the LC3 protein
pool in the internal autophagosomal surface [95].
Subsequently, a series of coordinated events mediate
fusion of autophagosomes with lysosomes, to generate auto-
lysosomes, the final compartments where degradation of the
cargo takes place. However, autophagosomes must first fuse
with early and/or late endosomes to form organelles known
as amphisomes, prior to fusion with lysosomes [96]. Factors
associated with the formation of autolysosomes include
motor proteins from the dynein, kinesin and myosin protein
families, which facilitate the movement of the autophago-
somes along the microtubules and actin filaments towards
the perinuclear region of the cell, where lysosomes usually
concentrate [97,98]. Fusion of autophagosomes with lyso-
somes requires tethering, which involves the activation of
the GTPase RAB7 by the CCZ1-MON1A complex, and its
subsequent interaction with the homotypic fusion and vacu-
ole protein sorting (HOPS) complex. The HOPS complex is
required to engage soluble N-ethylmaleimide-sensitive
fusion attachment protein receptor (SNARE) proteins, includ-
ing syntaxin 17 (STX17), vesicle-associated membrane protein
8 (VAMP8), synaptosomal-associated protein 29 (SNAP-29)
and the synaptobrevin homologue YKT6 [99,100]. Additional
factors, which sometimes are tissue-specific, participate in the
regulation of autophagosome–lysosome fusion [99].
The autophagosomal membrane and the cargo are broken
down inside autolysosomes by lysosomal hydrolases such as
cathepsin B, L and D. As LC3-II is also incorporated on the
internal surface of the autophagosomes, part of this lipidated
protein remains trapped in the interior of autolysosomes and




72. Role of autophagy during arboviral
infections
2.1. Preface
Viruses depend on and exploit the host-cell machinery for
progeny production, thereby modulating and hijacking mul-
tiple cellular pathways. In this review, we will summarize key
concepts related to the induction and regulation of auto-
phagy over the course of DENV, WNV, ZIKV and CHIKV
infections and delineate how this pathway may control the
outcome of the infection. We will focus on macroautophagy,
as microautophagy and chaperone-mediated autophagy have
not yet been studied in the context of these viruses.
There are multiple contradictory results and conclusions in
the literature. Although some of these discrepancies could be
due to differences in the virus strains and cell lines used
for the experiments, others areprobably linked to thewayautop-
hagy assays have been performed and interpreted. Researchers
often examine the steady-state levels of autophagy marker pro-
teins like LC3 or p62, but this does not provide information on
the dynamics of this process, the autophagic flux. An increase
in the steady-state levels of LC3-II can indicate either induction
(i.e. more of this conjugate is produced) or inhibition (i.e. there
is no turnover of LC3-II in the lysosomes). Analogously, a
decrease in LC3-II levels can also indicate either induction
(i.e. LC3-II is rapidly degraded) or inhibition (i.e. LC3-I fails to
be converted into LC3-II). Moreover, most of the compounds
currently used to inhibit or activate autophagy, like 3-methyla-
denine (3-MA), wortmannin or rapamycin, are not specific,
and consequently, eventual effects on the virus life cycle could
be indirect and not linked to a change in the autophagic flux.
Similarly, numerous recent discoveries have revealed that ATG
proteins are involved in other cellular pathways [103–105] and
consequently the depletion of only one of them is not sufficient
to conclude that autophagy is involved in a specific aspect of the
virus replication cycle. In this regard, it is important to note that
there are the so-called non-conventional types of autophagy,
which do not require the entire ATG machinery. As a result,
the depletion of a single ATGprotein does not always guarantee
the block of autophagy. Finally, it is important to also keep in
mind that LC3-positive puncta, which is often used as a
method to assess autophagy induction, do not always represent
autophagosomes [106–109].
Thus, the objective of this review is to summarize the lit-
erature on the interaction of autophagy and DENV, WNV,
ZIKV and CHIKV, and to highlight the experimental
approaches to allow the reader to have a critical evaluation
of the currently available evidences.2.2. Dengue virus
2.2.1. Autophagy induction and autophagic flux during infection
The induction of autophagy during DENV infection has been
observed in numerous mammalian cell lines, including
Huh7, HepG2, U937, HUVEC, HEK293, HeLa, BHK-21, Vero
and Madin-Darby canine kidney (MDCK) cells, by analysing
the presence of autophagosomes [110–117]. The first report,
by Lee and colleagues, showed the induction of GFP–LC3
puncta formation in DENV-infected Huh7 cells in a multi-
plicity-of-infection (MOI)-dependent manner [110]. Theseobservations were soon corroborated by others in diverse
cellular models and using different methods [111–113]. For
example, LC3 puncta accumulation was shown to correlate
with LC3 lipidation (i.e. LC3-II synthesis), as assessed by wes-
tern blot [110,112,114]. Similarly, enhanced LC3-I conversion
into LC3-II and an increased number of autophagy-like vesicles
were observed at 24, 36 and 48 h post-infection (hpi) bywestern
blot and electron microscopy, respectively, in endothelial
HUVECs and EA.hy926 cell models [117]. Moreover, DENV-
induced autophagosome biogenesis was shown to be
decreased by the PI3 K-III inhibitors 3-MA and wortmannin,
further supporting the notion that DENV infection induces
autophagy [110,112]. As UV-inactivated DENV is unable to
induce LC3-positive puncta formation and bona fide autopha-
gosomes in infected cells, this observation indicated that
active viral replication triggers autophagy [110]. Interestingly,
ectopic expression of the DENV NS4A protein was observed
to induce LC3 puncta formation and LC3 lipidation in HeLa
cells, suggesting that NS4A may trigger the putative autopha-
gic response [112]. Similarly, treatment of HMEC-1 endothelial
cells with DENV NS1 protein induced p62 degradation, LC3-I
to LC3-II conversion and the presence of LC3 puncta as
assessed by western blot and immunofluorescence staining
[118]. It is interesting to note that DENV NS1 increased the
permeability of these cells and vascular leakage in BALB/c
mice, a phenomenon that was demonstrated to be dependent
on autophagy [118]. Additional in vivo models and studies
involving primary cell culture have helped to confirm some
of the described in vitro observations. For example, DENV
also induced the formation of autophagosomes in primary
human monocytes, which are considered important targets
during DENV infection [110]. Additionally, brains of suckling
mice infected with DENV showed an induction of endogenous
LC3-positive puncta formation at 5 days post-infection (dpi)
[114]. In addition, DENV-infected animals displayed a
reduction in the p62 levels and induction of LC3-II at 3 and
5 dpi, further demonstrating an autophagy induction [114].
Altogether, these studies indicate that autophagosome for-
mation is initiated upon DENV infection, possibly via NS4A
and NS1 expression and may depend on the autophagy
PI3 K-III complex.
Autolysosome formation and increase in autophagic flux
upon DENV infection have been observed in several studies
[110,111], though one investigation reached an opposite con-
clusion [113]. Treatment of DENV-infected Huh7 cells with
vinblastine, a microtubule disrupting agent that also inhibits
autophagosome–lysosome fusion, enhanced LC3-II levels
when compared to untreated-infected cells, as assessed by
immunoblotting [110]. Moreover, co-localization of LC3
puncta with the lysosomal marker LAMP1 and the Lyso-
tracker dye was observed in Huh7 and Huh7.5 cells at 24
and 36 hpi with DENV, which was suggested to indicate an
enhancement of the autophagic flux [110,111]. In another
study, however, LC3 puncta did not co-localize with
LAMP2 at 36 hpi in DENV-infected Huh7 cells, although
autophagy was induced as assessed by measuring the
steady-state and flux levels of LC3-positive vesicles by quan-
titative image-based flow cytometry [113]. Moreover,
bafilomycin A1, an inhibitor of autolysosome acidification
and hence cargo degradation, did not lead to an increase in
GFP–LC3 puncta accumulation in DENV-infected cells,
suggesting an impairment in autophagic flux. In contrast to




8autophagosome formation but inhibits the autophagic flux
[113]. It is difficult to determine why very similar studies
obtained different results. This discrepancy may be related
to the method employed to evaluate the autophagic flux (con-
focal microscopy versus image-based flow cytometry versus
western blot), the evaluated time points or the compound
used to inhibit lysosomal degradation (vinblastine versus
bafilomycin A1). Nonetheless, it remains to be firmly estab-
lished whether DENV infection induces or blocks
autophagic flux. The use of alternative assays like the one
based on the RFP–GFP–LC3 tandem construct [119] could
be of help in solving this issue.
2.2.2. Is autophagy induction beneficial or detrimental
for DENV replication?
Although it is clear that autophagy is induced in DENV-
infected cells, the role of this pathway in the replication of
the virus is, however, more intricate and complex. Contrast-
ing results have been published which will be addressed
below (table 2).
2.2.2.1. Evidence pointing towards a beneficial effect of
autophagy in DENV infection
Lee and co-workers found that infectious virus particle pro-
duction was significantly decreased in Atg52/2 knockout
mouse embryonic fibroblasts (MEFs) compared to the control,
thereby suggesting that an intact autophagy pathway pro-
motes viral replication and release [110]. Other lines of
evidence indicating a proviral role of autophagy in DENV
replication include studies using drug inhibitors and/or
siRNAs that target different steps of autophagy and func-
tional groups of ATG proteins. For example, treatment with
3-MA or wortmannin, and ATG12 or BECN1 siRNA-based
silencing, were found to decrease viral replication and infec-
tious viral titres in diverse cell types [110–112,124,128].
Conversely, treatment with rapamycin, a potent stimulator
of autophagy through mTORC1 inhibition, increased DENV
infectious particle production in a dose-dependent manner
[110,124]. In a recent study, however, it has been shown
that DENV infection and egression are unaltered in ULK1,
BECN1 or ATG5 knockout HeLa cells, whereas viral replica-
tion was impaired in cells lacking ATG9, LC3B or VPS34,
knockout cells suggesting that this virus only exploits specific
autophagy components [131]. Similar to the results observed
in vitro, treatment of suckling mice with rapamycin promoted
viral replication as shown by an increase in DENV titres,
which correlated with a more severe clinical outcome and a
reduction in the survival rate of the mice [114]. However, it
is worth mentioning that rapamycin is a known immune-
suppressor [141,142], and therefore, these results need to be
carefully interpreted. Additionally, it was also shown that
the treatment of suckling mice with 3-MA, which inhibited
LC3-II synthesis and p62 degradation, improved the survival
rate of the mice and their clinical scores [114]. In a different
murine model, the use of SP600125 to inhibit JNK activation
in mice infected with DENV, reduced LC3-II levels, viral
titres, disease symptoms and prolonged the survival rate of
the infected mice [127]. Collectively, the above evidence
suggests that autophagy, or at least specific autophagy com-
ponents, are required for successful DENV infection in
mammalian cell lines and probably also in vivo. Of note,these same components are also involved in other pathways,
like the recruitment of LC3 onto endosomes, for example,
during LC3-mediated phagocytosis [109].
Several studies have focused on the possible mechanisms
by which autophagy is beneficial for the virus. Early
observations suggested that DENV RNA replication occurs
within autophagy-associated vesicles, but other studies have
challenged this view. In HepG2 cells, components of the
translation/replication machinery like NS1 and double-
stranded RNA (dsRNA), which marks active sites of viral
replication, were found to co-localize with marker proteins
that label amphisomes, such as mannose-6-phosphate recep-
tor, LAMP1 and LC3 [124,143]. Partial co-localization of
NS1 and LC3 puncta was also detected in brain tissues
from DENV-infected mice [114]. By contrast, no detectable
co-localization between LC3 and the viral proteins NS1 and
NS3, or dsRNA, was observed in DENV-infected Huh7.5
cells [111]. Comparable results were published for DENV-
infected monocytic U937 cells [116]. Moreover, recent high-
resolution electron microscopy studies revealed that DENV
replication complexes assemble in extensive ER-associated
membrane rearrangements that form in an autophagy-
independent manner [40,144]. Thus, even if co-localization
between viral components and autophagy marker proteins
was observed in early studies, it is unlikely that DENV RNA
replication occurs in association with autophagosomes or
autophagy-derived vesicles.
Other studies evaluated the replication cycle of the virus to
delineate the step where autophagy promotes viral replication.
Heaton and co-workers revealed that neither entry nor viral
protein translation is affected in DENV-infected Huh7.5
cells treated with 3-MA or siRNA targeting BECN1 [111]. In
another study, autophagy was suppressed in BHK-21 cells by
spautin-1, an unspecific inhibitor of BECN1 de-ubiquitination,
and this severely hampered the specific infectivity of progeny
viral particles [115]. Stimulation of autophagy by nicardipine,
(a modulator of intracellular Ca2þ flux) or by rapamycin was
found to have the opposite effect (i.e. the specific infectivity
of progeny virions was increased), suggesting a possible
effect of autophagyon viralmaturation [121]. Ca2þ levels, how-
ever, probably influence numerous other cellular processes,
such as the enzymatic activity of furin [145], which is required
in the latest stages of viralmaturation in the TGN. In agreement
with these observations, intracellular DENV RNA levels in
ATG9, LC3B and VPS34 knockout HeLa cells are similar to
the control during the first 24 hpi; but they decrease at later
time points, suggesting an effect posterior to viral RNA replica-
tion processes and possibly first replication cycle [131]. Finally,
DENV cell-to-cell spread has been linked to specific com-
ponents of the autophagy machinery [126]. Extracellular
vesicles released from DENV-infected Huh7 cells were
reported to contain LC3-II, DENV proteins (E, NS1, prM/M)
and infectious viral RNA [126]. Interestingly, these vesicles
were also detected in the serum of a DENV-infected patient
[126]. The relevance of these LC3-II-containing vesicles for
viral spread in the context of human infection is still unknown.
Next to this, three independent studies proposed that the
virus benefits from the induction of lipophagy, the selective
autophagy of lipid droplets [111,120,128]. Lipophagy is
activated during DENV infection, thereby increasing the
b-oxidation rates and consequently ATP levels, which pro-
motes replication [111]. This phenomenon has been studied
in Huh7, Huh7.5 and HepG2 cells, where DENV infection
Table 2. Summary of the literature describing an antiviral or proviral role of autophagy or ATG proteins over the course of speciﬁc ﬂavivirus infections.
(a) DENV
(i) (in vitro)
cell type experimental approach role of autophagy a references
WT MEFs rapamycin treatment
3-MA treatment
proviral [110]










ATG12 and BECN1 siRNA
proviral [111]
HepG2 AMPKa siRNA (used as an inhibitor of
lipophagy during DENV infection)










KU812 Atg4BC74A overexpression proviral [122]
A549 rapamycin treatment
3-MA treatment




BECN1 and ATG7 siRNA
antiviral
U937 (ADE conditions) rapamycin treatment
L-asparagine treatment
Vps34dn overexpression
antiviral (mild effect) [116]
HepG2 (DENV-2) rapamycin treatment proviral [124]
3-MA treatment
L-asparagine treatment
HepG2 (DENV-3) rapamycin treatment proviral [125]
3-MA treatment
L-asparagine treatment




Atg52/2 MEFs — proviral [127]
Huh7 IRE1a inhibitor
IRE1a and eIF2a shRNA
SP600125 treatment
proviral (indirect) [127]







K562 (ADE conditions) rapamycin treatment
3-MA treatment
CRISPR-Cas9 knockout of ATG5
proviral [129]
HBMEC FAM134B siRNA antiviral (FAM134B, reticulophagy) [130]




animal model experimental approach role of autophagya references
suckling mice rapamycin treatment proviral [114]
3-MA treatment no effect
suckling mice SP600125 treatment proviral [127]
(b) WNV
(i) (in vitro)
cell type experimental approach role of autophagy a references
MCCs trehalose treatment no effect [132]
BSCs wortmannin treatment no effect
3-MA treatment proviral (unspeciﬁc effect)
BHK ATG5 shRNA no effect
Atg52/2 MEFs — no effect
Atg52/2 MEFs — antiviral (only at low infectious
dose, MOI 0.01)
[133]
HeLa TAT-BECN1 peptide antiviral
Atg52/2 MEFs (m5–7 clone,
suppresses Atg5 expression
upon doxycycline treatment)
— no effect [134]
HEK293T ATG7 siRNA no effect
HeLa TAT-BECN1 peptide antiviral [135]





cell type experimental approach role of autophagya references
















proviral (although NS3 protein is
increased by wortmannin and
decreased by BECN-1 shRNA)
[139]













HBMEC FAM134B siRNA antiviral (FAM134B, reticulophagy) [130]
HeLa CRISPR-Cas9 knockout of ULK1, BECN1,
ATG9A, VPS34 and LC3B
proviral [131]
(ii) (in vivo)
animal model experimental approach role of autophagya references
Atg16l1HM mice — proviral [140]
WT C57BL6 mice HCQ treatment proviral




11leads to a decrease in the size of lipid droplets and free fatty
acid levels at 48 hpi, which correlates with an increase in LC3
puncta formation [111,128]. Furthermore, lipid droplets were
found to co-localize with autophagosomal and lysosomal
marker proteins to a higher extent in cells exposed to DENV
than inmock-treated cells [111]. In linewith these observations,
3-MA treatment and silencing of ATG12 or BECN1 to inhibit
autophagy, restored lipid droplet mass and decreased co-local-
ization of LC3 with lipid droplets [111]. A subsequent study
demonstrated that DENV-induced lipophagy, but not basal
autophagy, depends on AMPK kinase activity and inhibition
of mTORC1 signalling [120]. Moreover, it was recently found
that during DENV infection of HepG2 cells, NS4A and NS4B
viral proteins interact with Ancient ubiquitous protein 1
(AUP1), a lipid droplet-localized membrane protein [128].
This interaction drives the relocation of AUP1 from lipid
droplets to autophagosomes, triggering lipophagy [128].
Furthermore, deletion of AUP1 arrests DENV-induced lipo-
phagy and impairs viral production [128]. Altogether, these
studies underscore the importance of lipophagy for DENV
replication cycle and highlight the role that NS4A and NS4B
play to hijack this pathway.
Additional components of the autophagy machinery have
also shown to play a role during DENV infection, specifically
in conditions of antibody-dependent enhancement (ADE). It
is generally accepted that pre-existing, cross-reactive, poorly
neutralizingantibodies can enhanceDENVinfectivityand repli-
cation in Fcg receptor-expressing cells, such as macrophages
andmonocytes, a process that eventually leads to vascular leak-
age [146]. Treatment of K562myelogenous leukaemia cells with
rapamycin prior to infection with DENV-antibody-enhancing
complexes, increased intracellular viral RNA levels at 48 hpi
[129]. Conversely, 3-MA treatment reduced intracellular
DENV RNA after infection. Furthermore, in ATG5 knockout
K562 cells, a decrease in intracellular viral RNA synthesis was
detected [129]. Moreover, DENV–antibody complexes led to
an increase in ATG12–ATG5 conjugate levels in monocytic
THP-1 cells, and ATG12 and ATG5 transcripts and ATG5
and LC3-II protein levels in K562 cells [129,147]. This led to a
negative regulation of retinoic acid-inducible gene I (RIG-I)and the melanoma differentiation-associated protein 5
(MDA-5) signalling pathways, which in turn dampened inter-
feron type I (IFN-I) response and promoted viral replication in
THP1 cells [147,148]. Moreover, in K562 cells, overexpression
of ATG5 impaired NF-kB activation, which eventually led to
increased DENV RNA [129]. In addition, in an independent
study, infection of pre-basophil-like KU812 and immature
mast-like HMC-1 cell lines with DENV in the presence of
cross-reactive enhancing antibodies was shown to induce
autophagy, and inhibition of this pathway through the gener-
ation of a KU812 stably expressing the mutant Atg4BC74A
reduced viral replication [122].
2.2.2.2. Evidence pointing towards an antiviral role of autophagy
in DENV infection
A few studies have suggested that autophagy may act as an
antiviral pathway in DENV infection, but evidences are less
compelling than those indicating that autophagy is proviral
(table 2). For example, induction of autophagy by rapamycin
in U937 monocytic cells resulted in a decrease in extracellular
virus output, whereas downregulation of autophagy by
L-asparagine had no effect in DENV infectious particle pro-
duction [116]. This finding was confirmed by another study
in which autophagy induction by rapamycin in monocytic
THP-1 cells significantly decreased the progeny DENV titre,
while 3-MA, or siRNA targeting BECN1 or ATG7-mediated
inhibition of autophagy increased the viral titre [123]. Studies
by the same authors additionally identified miR-146a as a reg-
ulator of both autophagy and innate immune responses during
DENV infection [123,149]. It was initially shown that
expression of miR-146a facilitates DENV replication by target-
ing TRAF6, an essential innate immune signalling adaptor that
activates the nuclear factor kappa-light-chain-enhancer of acti-
vated B cells (NF-kB) transcription factor and the production of
IFN-I [149]. In addition, miR-146a-mediated TRAF6 downre-
gulation blocked DENV-induced autophagy in THP-1 cells
[123]. Furthermore, silencing of ATG7 or BECN1 by siRNA
transfection in DENV-infected cells decreased the production




12autophagy inmodulating DENV-induced immune response in
monocytic cells [123].
Furthermore, the autophagy receptor p62 was described to
directly hamper DENV replication [113]. Indeed, reduced
DENV replication was observed in Huh7 cells stably overex-
pressing p62 [113]. Interestingly, DENV was found to
counteract p62 expression, as the expression level of p62 was
shown to be reduced during infection, even when the autopha-
gic flux was progressively blocked with bafilomycin A1.
Moreover, DENV-induced p62 reduction was abolished by
treatment with the proteasomal inhibitor epoxomycin,
suggesting that DENV induces p62 proteosomal degradation
to subvert an autophagy-mediated antiviral response [113]. Of
note, these data have to be pondered in the light of the fact
that p62 also represents a hub to coordinate autophagy and oxi-
dative stress (e.g. [150,151]).l.9:1900092.2.3. Autophagy crosstalk with other cellular stress pathways
McLean and co-workers found that DENV infection of
HEK293T, HeLa, Vero, MDCK cells and MEFs prevents cell
death caused by several stimuli, including DNA damage
through camptothecin treatment, inhibition of kinases induced
with staurosporine and protein synthesis inhibition by cyclo-
hexamide [112]. This cytoprotective effect was abolished in
ATG52/2 MDCK cells, suggesting that autophagy stimulation
during DENV infection is a prosurvival and proviral mechan-
ism [112]. In agreement with the aforementioned observation,
3-MA treatment further reduced the number of surviving
DENV-infected cells, indicating that autophagy may contrib-
ute to cell survival under these conditions [117]. Indeed, in
the same study, autophagy inhibition was found to upregulate
apoptosis in HUVECs and EA.hy926 cells [117]. Finally, it was
identified that NS4A overexpression was sufficient to confer
protection from cell death induced by camptothecin or stauros-
porine treatment in MDCK cells, and this protection was
associated with the induction of autophagy [112].
Additional evidence indicates that DENV also activates
the protein kinase RNA-like endoplasmic reticulum kinase
(PERK) branch of the UPR at early time points after infection
in MDCK and Huh7 cells and in MEFs, which can trigger
autophagy and ROS production, and through a positive-
feedback loop further stimulates autophagy [115,127]. In
DENV-infected Huh7 cells, PERK signalling leads to eIF2a
phosphorylation, thereby enhancing the translation of ATF4
and ultimately upregulating the expression of ATG proteins
(e.g. ATG12) and autophagy at 12 and 24 hpi [127]. The ino-
sitol requiring kinase 1(IRE1a) and c-Jun N-terminal kinase
(JNK) branch of the UPR is required for this autophagy
stimulation [127]. IRE1a–JNK is a major signalling pathway
that induces BCL2 phosphorylation and causes dissociation
of the BECN1–BCL2 complex to release BECN1 and thereby
promotes autophagy [152]. Indeed, blocking JNK activation
using the specific inhibitor SP600125 in DENV-infected
mice, reduced DENV-induced autophagy [127].
Collectively, these studies suggest a mutually exclusive
relationship between autophagy and apoptosis, and indicate
that the UPR and the JNK signalling pathways are important
regulators of autophagy during DENV infection. However,
they also evoke the possibility that autophagy is not directly
subverted by DENV but it could rather represent a prosurvi-
val response of the cell to adapt to stress.2.3. West Nile virus
Autophagy induction duringWNV infection has been found to
be cell-type specific. For example, infection of Vero cells stably
expressing GFP–LC3 with the highly pathogenic strain
New York 99 (WNV-NY99) led to more pronounced steady-
state levels of LC3 puncta and LC3 lipidation at 24 hpi when
compared to mock-infected control cells, although no effects
on p62 levels were observed [132]. Similarly, an increase in
steady-state amounts of LC3 puncta and lipidated LC3 were
seen in SK-N-SH, a neuroblastoma cell line, infected with
WNV-NY99 but at an earlier time point (6 hpi) [133]. Further-
more, SK-N-SH cells treated with the lysosomal protease
inhibitors E64d and pepstatin A had increased LC3 lipidation
following WNV-NY99 infection, indicating that WNV indeed
enhances autophagic flux [133]. In agreement with this obser-
vation, Vero cells exposed to WNV-NY99 and treated with
bafilomycin A1 or chloroquine (CQ), also showed more LC3-
II accumulation when compared to the control cells [132].
Moreover and similarly to what has been observed for
DENV, 3-MA was found to inhibit LC3-positive puncta for-
mation in WNV-infected Vero cells [132]. Similarly, ATG5
knockdown in BHK-21 cells using shRNA also reduced LC3-
positive puncta formation in WNV-infected cells [132].
Lastly, increased steady-state LC3 lipidation was detected at
24 and 48 hpi with WNV-NY99 in a three-dimensional CNS
model [132]. By contrast, no enhanced steady-state LC3 lipida-
tion was detected following infection with WNV-NY99 in
HEK293T, Huh7, Huh7.5, A549 cells and human skin fibro-
blasts (HFF) [134]. Collectively, these observations suggest
that the induction of autophagy following WNV infection is
cell-type specific. Alternatively, the discrepancies can be
explained by differences between the studies (e.g. the MOI
used, the analysed time points, inherent susceptibility of the
cells to infection, the metabolic cell status and the autophagy
measurement method). Therefore, a comparative study
should be performed using cell lines that have previously
shown contradictory results, to be able to pinpoint whether
this pathway is induced by WNV infection. The virulence of
theWNV strain, however, does not appear to be a determinant
factor as a direct comparison ofWNV-NY99 and a low virulent
KenyanWNV isolate appeared to equally stimulate autophagy
in Vero cells, as assessed through the analysis of steady-state
levels of LC3B-II at 24 hpi by immunoblotting [132]. Infection
of Vero cells expressing GFP–LC3 with multiple variants of
WNV (B13, ArD27875, Egypt101 and B956), however, resulted
in GFP–LC3 puncta accumulation and in increased steady-
state levels of lipidated LC3, as assessed by western blot at 24
and 48 hpi. In comparison, compared to the uninfected control,
WNV-NY99-infected Vero cells did not redistribute the GFP–
LC3 signal and the steady-state levels of LC3-II did not
change [136]. The authors of this study suggested that
mutations in theNS4A andNS4B ofWNVcould be responsible
for the discrepancies but further in vitro and in vivo characteriz-
ation of these mutants is required to eventually understand
the molecular mechanisms behind these discrepancies in
autophagy regulation between WNV strains [136,153].
The role of autophagy in promoting or restricting WNV
replication is also a controversial subject (table 2). While
some reports indicate that autophagy modulation does not
affect the virus replication [132–134], other studies suggest
otherwise [133,135].Nodifferences in viral titreswere observed




13targeting ATG7 compared to the cells treated with an siRNA
control [134]. In line with this result, treatment of primary
mouse cortical cultures (MCCs) with trehalose, an mTORC1-
independent inducer of autophagy, did not have a significant
effect on progeny WNV infectious titres at 72 h when infected
with an MOI of 3 [132]. In addition, inhibition of Atg5 with
shRNA had no effect on WNV infectious particle production
from 6 to 24 hpi as compared to cells transduced with a
shRNA control [132]. On the other hand, PI3 K-III inhibitors
3-MA and wortmannin significantly reduced viral titres of
WNV-NY99 in organotypic brain slice cultures at 72 hpi,
although this was suggested to be related to pleiotropic effects
of these compounds [132]. Similarly, Vero cells treated with 3-
MA released less WNV-B13 infectious virus particles, though
no effect was observed for WNV-NY99, indicating a strain-
specific effect [136]. On the contrary, another study showed a
significant enhancement in progeny virus particle production
at 24 and 48 hpi but not at 72 hpi following infection with
WNV-NY99 at MOI 0.01 in Atg52/2 MEFs when compared
to Atg5þ/þ MEFs or Atg52/2 cells back-transfected with Atg5
[133]. Additionally, they showed that Atg52/2 MEFs had
higher levels of WNV genomic RNA than parental cells at
6 hpi, as measured by RT-qPCR. No effect was, however,
seen at higher MOIs (e.g. MOI 0.1 and 1) [133]. Interestingly,
treatment of HeLa cells with TAT-BECN1, a potent autop-
hagy-inducing peptide, decreased WNV titres without
affecting viral entry or cell survival [133,135]. Similarly, treat-
ment of WNV-infected (strain Egypt 101) neonatal mice with
the TAT-BECN1 peptide, led to a pronounced reduction in
brain viral titres, clinical paralysis and mortality caused by
the virus [135]. Overall, these data suggest that even though
autophagy is not required for WNV replication, strong induc-
tion of this pathway could have a detrimental effect on the
virus, possibly due to non-specific degradation of viral com-
ponents or other antiviral pathways modulated by autophagy.
WNV-NY99 infection leads to ER stress and UPR induc-
tion, though this has been mainly associated with the
initiation of apoptosis in SK-N-MC neuroblastoma cells
rather than autophagy [154]. Furthermore, UPR activation
appears to be strain-specific and cell-type-dependent, as the
attenuated Kunjin WNV subtype only activates PERK-
mediated translation and CHOP transcription in Vero cells,
whereas WNV-NY99 was described to upregulate all three
pathways of the UPR (PERK, IRE1a and ATF6) in SK-N-MC
cells [154,155]. Moreover, comparable levels of spliced XBP1
were observed for different WNV strains in Vero cells, which
is indicative of similar UPR induction, yet not all of these
strains were found to induce autophagy [136]. Together, this
shows that the importance of the cellular stress response in
autophagy induction is not exactly clear and future studies
are required to address this question.
2.4. Zika virus
The interaction between ZIKV and autophagy has only
recently been described. Electron micrographs of primary
skin human fibroblasts infected with a clinical ZIKV isolate
from French Polynesia showed the presence of double-mem-
brane vesicles resembling autophagosomes at 72 hpi [137].
Enhanced autophagosome formation has also been observed
in HeLa and HUVEC cell lines, and in MEFs, which displayed
increased LC3 lipidation and p62 degradation upon ZIKV
infection [138,139]. In addition, LC3-I to LC3-II conversionand LC3 puncta formation were observed at 12 hpi in the
human trophoblast cell type JEG-3, following exposure to the
Brazilian ZIKV strain Paraiba 2015 in the presence and absence
of bafilomycin A1 [140]. Furthermore, accumulation of LC3-
positive puncta co-localizing with the viral E protein in proxi-
mity to the ER was seen in HFF1 cells at 24 hpi [137]. These
findings led the authors to hypothesize that autophagosomes
are the sites of ZIKV replication [137]. This notion, however,
has been challenged by a more recent study in which ZIKV
replication factories were described to be tightly linked to ER
membrane invaginations surrounded by rearrangements of
the host cell cytoskeleton [156].
Multiple studies reported enhanced autophagic flux during
ZIKV infection in different in vitro and in vivo systems and inde-
pendent of the strain used [137–140]. HUVEC cells transduced
with a lentivirus system encoding mTagRFP-mWasabi-LC3,
which allows differentiation of autophagosomes (Wasabiþ/
RFPþ puncta) from autolysososmes (RFPþ puncta), demon-
strated an increase in the autophagic flux from 18 to 24 hpi
following infection with ZIKV strain GZ01 [139]. Moreover,
due to the association of ZIKV infection with microcephaly
[157,158], several efforts have been made to dissect the role of
autophagy in ZIKV infection during neuronal differentiation
in forming brains. For example, three ZIKV strains of diverse
origin (i.e. MR766, IbH30656 and H/PF/2013) were observed
to enhance LC3-I conversion into LC3-II in fetal NSCs
(fNSCs) when the autophagic flux was monitored in the pres-
ence and absence of bafilomycin A1 [138]. Furthermore,
steady-state p62 levels were reduced from 6 to 24 hpi, which
is consistent with a possible induction of autophagy [138]. Fur-
thermore, an in vivo study using a mouse model for maternal–
fetal transmission of ZIKV confirmed the results observed in
the previous in vitro studies [140]. Cao and colleagues reported
an increase in steady-state levels of LC3-II and a decrease of
p62 in the entire placenta of animals infected with ZIKV
strain Paraiba 2015 [140]. Lastly, the possible role of virally
encoded NS proteins in autophagy induction was investigated
inmore detail. Lentivirus-based overexpression of ZIKVNS4A
or NS4B led to GFP–LC3 puncta accumulation in HeLa cells,
and increased LC3 lipidation in fNSC when the autophagic
flux was assessed in the presence and the absence of bafilomy-
cin A1. Co-expression of both viral proteins further enhanced
the effect, by impairing Akt-mediated positive regulation of
mTORactivity [138]. Collectively, the results from these studies
show that autophagy could be initiated viaNS4A andNS4B by
regulating mTOR activation. However, how these proteins
interfere with Akt signalling remains to be understood.
Several studies have shown that autophagy induction is
beneficial for ZIKV replication and pathogenesis. Treatment
of diverse cell types (i.e. JEG-3 cells, primary fibroblasts or
fNSCs) with the mTOR inhibitors Torin-1 or rapamycin upon
ZIKV infection, resulted in a concomitant increase in autopha-
gosome formation and viral replication, whereas treatment
with the inhibitors 3-MA or CQ decreased viral replication
[137,138,140]. Similarly, treatment of HUVECs with wortman-
nin and CQ significantly decreased ZIKV titres [139]. In line
with these observations, infection of Atg32/2 and Atg52/2
MEFs with ZIKV reduced virus replication compared to con-
trol MEFs [138]. Reduced infectious virus titres were also
observed in ATG3- or ATG13-depleted fNSCs, or BECN1-
silenced HUVECs [138,139]. In agreement with these studies,
knockout of ULK1, ATG9, BECN1, VPS34 or LC3B in HeLa




14percentage of infected cells at 48 hpi [131]. In addition, treat-
ment of pregnant mice with the autophagy inhibitor
hydroxyl-CQ (HCQ), reduced ZIKV titres in the placentas of
these mice without influencing the systemic maternal infection
[140]. Also, a pronounced decrease in ZIKV titres has been
detected in the placentas of virus-inoculated pregnant mice
carrying a hypomorphic allele ofAtg16l1,whichwas correlated
with less pathological damage [140]. Finally, expression of
ZIKV NS4A and NS4B in fNSCs caused an impairment in
neurosphere formation anddifferentiation capacity, a phenom-
enon thatwas correlatedwith upregulation of autophagy [138].
Altogether, these studies highlight that ZIKV-induced autop-
hagy has a proviral effect in multiple contexts, hence
potentially contributing to the development of the severe clini-
cal manifestations observed in human neonates.
While induction of bulk autophagy is proviral for ZIKV, a
recent study suggests that reticulophagy is part of the cellular
antiviral response [130]. Downregulation of Reticulophagy
regulator 1 (FAM134B), a specific reticulophagy receptor
[159], by siRNA-mediated knockdown, boosts intracellular
viral RNA levels and infectious titres of both ZIKV and
DENV, in human brain microvascular endothelial cells
(HBMECs) [130]. The authors of this study showed that
FAM134B is cleaved by the flavivirus NS2B3 protease, to
facilitate the expansion of the ER rather than its degradation
[130]. In addition, NS2B3 is able to disrupt viral protein
sequestration in reticulophagy-derived autophagosomes, as
demonstrated by the absence of FAM134B- and NS3-positive
puncta in U2OS cells co-transfected with DENV NS2B and
FAM134B carrying a mutation in the LC3-interacting
domain [130]. These results suggest that FAM134B, and in
general reticulophagy, may act as a restriction factor for infec-
tion. The involvement of other ATG proteins in this context,
however, has not been examined and viral proteins were
shown to localize with FAM134B but not directly with LC3
[130]. As a result, further studies are required to determine
whether FAM134B ablation is indeed impairing reticulophagy
during ZIKV infection as other selective autophagy receptors
are also known to be involved in this pathway [160]. Nonethe-
less, an emerging picture could be that while bulk autophagy
is beneficial for ZIKV infection, this virus targets FAM134B to
assure that the ER and viral proteins are not turned over.
2.5. Chikungunya virus
2.5.1. Autophagy induction and autophagic flux during infection
Hallmarks of the induction of autophagy during CHIKV infec-
tion have been reported for multiple human cell lines,
including HEK293, HeLa, HFF and U-87 MG, and also in
MEFs and mice using diverse methods [161–163]. Accumu-
lation of GFP–LC3-positive puncta was detected from 4 to
48 hpi following CHIKV infection in MEFs, HEK293, HeLa
and human glioblastoma U-87 MG cells expressing GFP–
LC3 by fluorescence microscopy and flow cytometry
[161–164]. Furthermore, electron microscopy analyses in
HeLa and HEK293 cells exposed to CHIKV revealed the
accumulation of membranous vesicles reminiscent of autopha-
gosomes [161,163]. In line with these observations, LC3-I
conjugation to PE to form LC3-II has been observed in HeLa
cells and MEFs between 5 and 24 hpi by western blot analysis
[162,163]. Furthermore, a reduction in p62 cellular levels in
HeLa cells infected with a clone-derived CHIKV-37997 wasobserved at 15 hpi [163]. In another study, however, the
authors failed to detect accumulation of LC3-II in CHIKV-
infected HepG2 cells whereas the same authors did observe
enhanced LC3-II accumulation in HeLa cells challenged with
CHIKV [165]. This discrepancy is not fully understood yet,
and the observed differences between the two cell lines may
just reflect differences in the steady-state levels of LC3-II, as
the autophagic flux was not investigated. Active replication
of CHIKV is required for inducing autophagy, because UV-
inactivated virus is unable to enhance LC3-positive puncta
formation and LC3-I conversion into LC3-II in MEFs [162].
Although it is not exactly known how CHIKV replication
induces autophagy, a study for the closely related Semliki
Forest virus (SFV) revealed that accumulation of autophago-
somes might depend on the expression of the glycoprotein
spike complex [166]. It this case, however, autophagosome
accumulation was a result of inhibition of autophagosome
degradation rather than an active initiation of an autophagic
response [166]. Similar to the in vitro studies, higher LC3-II
levels have also been observed in a neonatal mouse model
for CHIKV at 3 dpi [163]. These data collectively suggest that
CHIKV replication may initiate an autophagic response
in vitro and in vivo.
Two independent studies reported co-localization of LC3
puncta with the lysosomal marker protein LAMP1 in HeLa
cells infected with CHIKV ECSA genotype or CHIKV-21
strain at MOI 1 and 10 at 24 hpi, which indicates an induction
of the autophagic flux that leads to the fusion between autop-
hagosomes and lysosomes [162,165]. Experiments using the
tandem construct expressing RFP–GFP–LC3, which allows
to distinguish between autophagosomes (i.e. RFPþ/GFPþ
puncta) from the acidic autolysosomes (i.e. RFPþ/GFP2
puncta) corroborated these findings [162]. Altogether, these
results indicate that autophagy is probably triggered over
the course of a CHIKV infection and that it culminates in
autolysosome formation.2.5.2. Is autophagy induction beneficial or detrimental
for viral replication?
Although early studies on CHIKV and autophagy suggested
an antiviral role of this pathway in human and murine cell
lines, more recent evidence has revealed proviral effects and
the results of these studies will be outlined below (table 3).2.5.2.1. Evidence pointing towards a beneficial effect of
autophagy in CHIKV infection
Multiple studies have highlighted that autophagy induction
promotes CHIKV replication in human cells. For example,
HEK293 pre-treated with 3-MA or BECN1 knockdown,
reduced the percentage of CHIKV-infected cells, the expression
levels of the E1 and C proteins, and the release of viral RNA
copies in culture supernatants [161]. Pre-treatment of
HEK293with rapamycin, on the other hand, enhanced the per-
centage of infected cells, E1 glycoprotein expression and viral
RNA in the culture supernatants [161]. Similarly, autophagy
induction with rapamycin in HeLa cells significantly increased
CHIKV replication and viral production at 15 and 24 hpi as
assessed by FACS and TCID50, while inhibition using wort-
mannin, or BECN1 or ATG7 knockdown restricted viral
replication [163]. These results indicate that autophagy
Table 3. Summary of the literature describing an antiviral or proviral role of autophagy or ATG proteins over the course of CHIKV infection.
(a) CHIKV
(i) (in vitro)





Atg52/2 MEFs — antiviral [162]
HeLa TAT-BECN1 peptide antiviral [135]
HeLa rapamycin treatment
wortmannin treatment
BECN1, ATG7 and NDP52 siRNA
proviral [163]
p62 siRNA antiviral
HLFs NDP52 siRNA proviral (NDP52)
p62 siRNA antiviral (p62)
WT MEFs NDP52 siRNA no effect
Atg52/2 MEFs — antiviral
(ii) (in vivo)
animal model experimental approach role of autophagya references
Atg16l1HM mice — no effect on viral titres but increased
pathogenesis (lethality)
[162]




15induction is beneficial for CHIKV replication and release in
human cell lines.
Interestingly, depletion of NDP52, an autophagy receptor
involved in several aspects of immunity [167], significantly
decreased CHIKV replication, protein translation and viral
titres in HeLa cells, suggesting that NDP52 positively controls
CHIKV replication [163]. In HeLa cells and primary human
labial fibroblasts (HLFs) exposed to CHIKV, NDP52 was
shown to co-immunoprecipitate with the nsP2 viral protein
and partially co-localized with dsRNA and nsP2, but not
LC3, in the perinuclear region [163]. These results indicate
that autophagy could promote CHIKV replication in human
cells, at least partly, by the interaction of NDP52 with nsP2
near the sites of protein translation. The beneficial role of
NDP52 was, however, not reproduced in MEFs, suggesting
that CHIKV replicates differently in mouse-derived cells [163].
2.5.2.2. Evidence pointing towards an antiviral role of autophagy
in CHIKV infection
An antiviral role of autophagy in CHIKV infection is based
on the observation of an increased percentage of infected
cells and progeny virus titres in Atg52/2 MEFs exposed to
MOI 0.1 CHIKV-GFP at 48 hpi [162]. Furthermore, knock-
down of p62 in HeLa cells was found to increase viral
replication at 15 hpi [163]. Additionally, it was shown that
the viral C protein is ubiquitinated and co-localizes with
both p62 and LAMP1, suggesting that autophagy, through
p62, targets CHIKV components to autolysosomes for degra-
dation to counteract infection [163]. Indeed, the interaction
between p62 and the viral C protein was shown by co-
immunoprecipitation, and treatment of CHIKV-infectedcells with bafilomycin A1 led to an increase of C protein
levels [163]. These results indicate an autophagy-mediated
antiviral response against CHIKV, enabled by the recognition
of the viral C protein by the p62 receptor, in both human and
mouse-derived cells.2.5.3. Autophagy crosstalk with other pathways
CHIKV induces the PERK and the IRE1a arms of the UPR in
U-87 MG cells [164]. Furthermore, activation of IRE1a corre-
lated with increased steady-state levels of LC3 lipidation, and
siRNA knockdown of IRE1a decreased CHIKV-induced LC3
puncta formation in MEFs [162]. ROS-mediated activation of
AMPK has also been observed in CHIKV-infected MEFs, and
this coincided with a decrease in mTOR phosphorylation at
24 hpi, which in turn correlated with an increase in LC3-I
conversion into LC3-II [162]. Therefore, autophagy initiation
is a downstream response to ER and oxidative stress activated
by CHIKV replication, possibly through the transcriptional
activation of several ATG genes [168,169].
CHIKV induces apoptosis via intrinsic and extrinsic
mechanisms [170], which have been suggested to be modu-
lated by autophagy as a mechanism that controls viral
pathogenesis early in infection. In CHIKV-infected HFFs
and MEFs, it was shown using imaging flow cytometry
that autophagy and apoptosis are mutually exclusive pro-
cesses, as autophagy initiation from 24 to 48 hpi prevented
CHIKV-induced caspase 3 activation [162]. Experiments
performed by the same authors revealed increased CHIKV-
induced lethality in mice carrying an Atg16l1 hypomorphic
allele in comparison to the WT mice [162]. This study,
however, did not find any differences in the viral titres of
r16these mice, and they suggested that autophagy does not
significantly affect viral infection in vivo.oyalsocietypublishing.org/journal/rsob
Open
Biol.9:1900093. Conclusion and perspectives: is there an
integrated view?
Despite the public health impact of arboviruses transmitted
to humans by mosquitoes, treatments and prophylactic
measures to combat these viruses remain scarce and therefore
the research on the virus–host interactions has intensified in
recent years. Overall, DENV, WNV, ZIKV and CHIKV appear
to activate autophagy either directly or indirectly through
diverse mechanisms. DENV and ZIKV were described to
actively initiate autophagy in several cellular models, poss-
ibly through the expression of NS4A, NS4B and/or NS1.
For WNV, however, autophagy induction is determined by
the cell type and the virus strain used. Site-directed mutagen-
esis studies can be performed to further address the role and
importance of the NS proteins in autophagy initiation during
flavivirus infection. CHIKV also triggers autophagy in most
of the cells types evaluated so far, although it remains to be
identified which CHIKV protein is associated with this cellu-
lar response. There is also evidence that autophagy is
induced through the activation of ER or oxidative stress as
a consequence of DENV and CHIKV infection. UPR induc-
tion, however, does not always trigger autophagy during
arboviral infection as conflicting results have been described
for WNV. Furthermore, the initiation of autophagy attenuates
cellular stress and was described to prevent cells from under-
going apoptosis. Therefore, at least for DENV and CHIKV,
the initiation of autophagy is ultimately beneficial for cell
survival and viral replication.
As we have highlighted throughout this review, the
measurement of the autophagic flux during arboviral infection
is technically challenging. In this regard, early investigations
mainly assessed changes in the steady-state levels of LC3-II
and p62 and the number of LC3-positive puncta. More
recently, the use of bafilomycin A1 and other lysosomal inhibi-
tors, assays based on the GFP–RFP–LC3 tandem construct,
and image-based flow cytometry have allowed us to properly
measure the autophagic flux. Based on these findings, early in
DENV infection autophagosomes are formed, whereas at later
time points in infection lysosomal degradation of autophago-
somes is impaired. This is in contrast to ZIKV, WNV and
CHIKV, for which autophagy induction was shown to
culminate in autophagosome degradation.
Once autophagy is triggered, a major research question
has been whether it positively or negatively influences arbo-
viral replication. This has represented an additional challenge
for the field, as several discrepancies were described, mainly
associated with cell type variations or to the methods
employed to investigate this subject. In this regard, and as
we have also emphasized throughout the review, the use of
compounds inducing and inhibiting autophagy-like rapamy-
cin or 3-MA is not optimal, as these molecules are known to
affect multiple cellular pathways. For this reason, genetic
approaches and methods based on the specific depletion of
ATG proteins from different autophagy functional clusters
should be the preferred experimental strategy in future
research. Most evidence points out that DENV, ZIKV and
CHIKV replication is promoted by autophagy, albeit in a
cell-type-specific manner. For example, lipophagy has beenproven to be beneficial for DENV and ZIKV replication in
human hepatic cell lines. In addition, DENV appears to
benefit from autophagy during progeny virus particle matu-
ration and spread, but the molecular mechanism remains to
be unveiled. For CHIKV, the interaction between nsP2 and
the NDP52 autophagy receptor in human cell lines ultimately
favours viral replication through an as yet unknown mechan-
ism. Although a proviral function for autophagy has also
been suggested for a specific WNV strain, more studies are
required to validate these results.
Other evidence suggests that autophagy contributes to the
removal of viral components during infection to relieve cellular
stress. This phenomenonwas described to occur duringCHIKV
infection inhumanandmurine cells, inwhich capsidubiquitina-
tion and its co-localization with p62 suggest xenophagic
degradation of this viral protein. On the same line, DENV and
ZIKV counteract autophagy, underscoring the notion that
autophagy acts as an antiviral response. For example, DENV
was described to block the autophagic flux by inducing proteo-
somal turnoverofp62.Moreover,DENV,WNVandZIKVcleave
the FAM134B reticulophagy receptor mediated by the NS2B3
protease. Also, studies performed in DENV-infected THP-1
and U937 cells, which both have a monocytic origin, concluded
that autophagy has an antiviral function, but the mechanism
underlying this role remains unidentified. Different laborato-
ries have attempted to exploit this potential antiviral role of
autophagy as a therapeutic strategy. In our view, themost inter-
esting approach constitutes the use of the autophagy-inducing
peptide TAT-BECN1 to counteract viral infection and the
pathological effects caused by WNV, ZIKV and CHIKV.
In conclusion, autophagy can have diverse outcomes in
DENV, WNV, ZIKV and CHIKV infection, and many ques-
tions arise from this apparent dual role of autophagy. For
example, it remains to be explored how DENV triggers and
benefits from lipophagy when the autophagic flux is
impaired. In addition, how does DENV prevent the for-
mation of autolysosomal vesicles later in infection?
Addressing these and other questions will provide crucial
information on the arbovirus replication cycle and the pro-
cess of autophagy. While studying autophagy, it is also
important to consider that ATG proteins participate in
many unconventional functions outside the autophagy
context [103–105] and different forms of non-canonical
autophagy also exist, which has been suggested to contribute
to DENV and ZIKV infections [131,171]. One should always
compare the results of different methods to firmly conclude
whether selective and/or non-selective types of autophagy
have a pro- or antiviral role during arboviral infection. There-
fore, interdisciplinary approaches involving experts in the
field of arbovirus and autophagy may be crucial to design
studies for a more thorough understanding of autophagy
and arboviruses.
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